NCT05968937View on ClinicalTrials.gov

Vaginal Baclofen Suppositories in Chronic Pelvic Pain

PHASE2RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

June 1, 2026

Conditions
Chronic Pelvic Pain Syndrome
Interventions
DRUG

20 mg baclofen vaginal suppository daily per vagina

20 mg baclofen vaginal suppository in Supposibase F daily per vagina - to be compounded by The Louisville Compounding Pharmacy

DRUG

Placebo

Vaginal suppository composed of Supposibase F daily per vagina

Trial Locations (1)

40205

RECRUITING

ULP Female Pelvic Medicine and Reconstructive Surgery - Springs Medical Center Suite 190, Louisville

All Listed Sponsors
lead

University of Louisville

OTHER

NCT05968937 - Vaginal Baclofen Suppositories in Chronic Pelvic Pain | Biotech Hunter | Biotech Hunter